Protection against cisplatin-induced nephrotoxicity by Cu(II)₂(3,5-diisopropylsalicylate)₄

REFERENCES

• Gandara DR, Perez EA, Weibe V, DeGregorio MW. Cisplatin chemo-protection and rescue: pharmacologic modulation of toxicity. Semin Oncol 1991; 18: 49–55.
   PubMed Web of Science ®Google Scholar
• Bodenner DL, Dedon PC, Keng PC, Katz JC, Borch RF. Selective protection against cisplatin-induced toxicity in kidney, gut, and bone marrow by DDTC. Cancer Res 1986; 46: 2751–2755.
   PubMed Web of Science ®Google Scholar
• Hamers FPT, Brakkee IH, Cavalletti F et al. Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res 1993; 53: 544–549.
   PubMed Web of Science ®Google Scholar
• Wolfgang GHI, Dominick MA, Walsh KM, Hoeschele JD, Pegg DG. Comparative nephrotoxicity of a novel platinum compound. cisplatin and carboplatin in male Wistar rats. Fundam Appl Toxicol 1994; 22: 73–79.
   PubMedGoogle Scholar
• Rybak LP, Ravi R, Somani SM. Mechanism of protection by diethyldithiocarbamate against cisplatin ototoxicity: antioxidant system. Fundam Appl Toxicol 1995; 26: 293–300.
   PubMedGoogle Scholar
• Hannemann I, Baumann K. Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 1988; 51: 119–132.
   PubMed Web of Science ®Google Scholar
• Sadzuka K, Shoji T, Takino Y. Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation. Biochem Pharmacol 1992; 43: 1872–1875.
   PubMed Web of Science ®Google Scholar
• Babu E, Gopal Krishnan VK, Sriganth INP, Gopal Krislittan R, Sakthisckaran D. Cisplatin-induced nephrotoxicity and the modulating effect of glutathione ester. Mol Cell Biochem 1995; 144: 7–11.
   PubMed Web of Science ®Google Scholar
• Somani SM, Ravi R, Rybak LP. Diethyldithiocarbamate protection against cisplatin nephrotoxicity. Antioxidant system. Drug Chem Toxicol 1995; 18: 151–170.
   PubMed Web of Science ®Google Scholar
• Satoh M, Naganuma A, Imura N. Effect of co-administration of selenite on the toxicity and antitumor activity ofcis-diaminodichloroplatinum given repeatedly to mice. Cancer Chemother Pharmacol 1992; 30: 439–443.
   PubMed Web of Science ®Google Scholar
• Naganuma A, Satoh M, Imura N. Prevention of lethal and renal toxicity of cis-diaminedichloroplatinum(II) by injection of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res 1987; 47: 983–987.
   PubMed Web of Science ®Google Scholar
• Basinger MA, Jones MN, Holscher MA. L-Methionine antagonism of cisplatinum-induced nephrotoxicity. Toxicol Appl Pharmacol 1990; 103: 1–15.
   PubMed Web of Science ®Google Scholar
• Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animals and tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351–358.
   PubMed Web of Science ®Google Scholar
• Nishikimi M, Rao N, Yai K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972; 46: 849–853.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol 1984; 105: 121–126.
   PubMed Web of Science ®Google Scholar
• Flohe L, Gunzler NV. Assays of glutathione peroxidase. Methods Enzymol 1994; 105: 114–121.
   Google Scholar
• Carlberg I, Mannervik B. Glutathione reductase. Methods Enzymol 1985; 113: 48/1 d90.
   PubMedGoogle Scholar
• Litterst CL, Schweitzer VG. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity. Res Commun Chem Pathol Phamiacol 1988; 61: 35–48.
   PubMed Web of Science ®Google Scholar
• Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods, 2nd edn. New York: Grune and Stratton, 1987; 66-72.
   Google Scholar
• Lowry OH, Rosenberg NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265–275.
   PubMed Web of Science ®Google Scholar
• Hussain K, Morris C, Whitworth C, Trammell CL, Rybak LP, Somani SM. 4-Methylthiobenzoic acid protection against cisplatic nephrotoxicity: antioxidant system. Fundam Appl Toxicol 1996; 32: 278–284.
   PubMedGoogle Scholar
• Kameyama Y, Gemba M. Cisplatin-induced injury to calcium uptake by mitochondria in glutathione-depleted slices of rat kidney cortex. Jpn J Phannacol 1991; 55: 174–176.
   PubMed Web of Science ®Google Scholar
• Zhang JC, Lindup WE. Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol 1993; 45: 2215–2222.
   PubMed Web of Science ®Google Scholar
• Sugihara K, Nakano S, Koda NI, Tanaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol 1987; 43: 247–252.
   PubMedGoogle Scholar
• Sinet PM, Carber P. Inactivation of the human CuZn-superoxide dismutase during exposure to 027 and 11202. Arch Biochem Biophys 1981; 212: 411–416.
   PubMed Web of Science ®Google Scholar
• Masuda H, Tanaka T, Takahama U. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun 1994; 203: 1175–1180.
   PubMed Web of Science ®Google Scholar
• Kim YK, Jung JS, Lee SH, Kim YVV. Effects of antioxidants and calcium on cisplatin-induced renal injury in rabbit renal cortical slices. Toxicol Appl Pharmacol 1997; 146: 261–269.
   PubMed Web of Science ®Google Scholar
• McGuiness JF, Proctor P, Demopoulos H. Amelioration of cisplatinum nephrotoxicity by orgotein (superoxide dismutase). Physiol Chem Phys 1978; 10: 296–277.
   Google Scholar
• Dobyan DC, Bull JM, Strebel FR, Sunderland BA, Bulger RE. Protective effect of 0O-beta-hydroxyethyl-rutoside on cisplatin-induced acute renal failure in the rat. Lab Invest 1986; 55: 557–563.
   PubMed Web of Science ®Google Scholar
• Hussain K, Morris C, Whitworth C, Trammell CL, Rybak LP, Somani SM. Protection by ebselen against cisplatic nephrotoxicity: antioxidant system. Mol Cell Biochem 1998; 178: 127–133.
   PubMed Web of Science ®Google Scholar